Category: Rare Blood Cancers

BPDCN: Diagnosis to Emerging Therapies

Hannah Levavi, MD, Tisch Cancer Center at Mount Sinai Hospital, New York, NY

Waldenström macroglobulinemia: What to Know in Practice

Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN

Mastocytosis: What Clinicians Need to Know

Marina Kremyanskaya, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, NY

Highlights from attending the 2023 ASH Annual Meeting

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

What’s New in the Treatment of BPDCN?

Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX

Mastocytosis: Insight into a Rare Blood Cancer

Jason Gotlib, MD, Stanford University School of Medicine, Palo Alto, CA

Scroll to Top